Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
about
Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?Evaluation of Transient Motion During Gadoxetic Acid-Enhanced Multiphasic Liver Magnetic Resonance Imaging Using Free-Breathing Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging.Dose-dependence of transient respiratory motion artifacts on gadoxetic acid-enhanced arterial phase MR images.
P2860
Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Intravenous Gadoxetate Disodiu ...... ized Placebo-controlled Trial.
@en
type
label
Intravenous Gadoxetate Disodiu ...... ized Placebo-controlled Trial.
@en
prefLabel
Intravenous Gadoxetate Disodiu ...... ized Placebo-controlled Trial.
@en
P2093
P2860
P1433
P1476
Intravenous Gadoxetate Disodiu ...... ized Placebo-controlled Trial.
@en
P2093
Brian C Allen
Chad M Miller
Claude B Sirlin
Michael S Middleton
Mustafa R Bashir
Scott B Reeder
Taylor R McClellan
Tracy A Jaffe
Utaroh Motosugi
P2860
P304
P356
10.1148/RADIOL.2016160482
P407
P577
2016-08-10T00:00:00Z